Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Imaging in Minimally Invasive Thoracic Surgery
NCT02621268Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in thoracic neoplasms (TN), sponsored by University of Pennsylvania. Primary endpoint: Ability of imaging system to detect expression of ICG in nodule/mass at 36 months. Started Nov 2014; status: completed.
02
Drugs
indocyanine green
03
Conditions
thoracic neoplasms (TN)
Beyond the preview
Go deeper on NCT02621268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02621268.